CARCINOGENIC ACTION OF P32 adrenal weight increase following ACTH administration. A number of workers (13) (14) (15) have reported a lack of correlation in the biological activities of various ACTH preparations. These findings have led to the recent viewpoint ( 15) that there are several adrenocorticotropic hormones having different biological activities. Until this question is resolved, conclusions are not justified concerning the pituitary or adrenal origin of the impairment in adrenal cholesterol depletion observed in the pyridoxine-deficient rat. One may not at present regard the depletion of ascorbic acid and cholesterol of the adrenal and its weight increase as comparable biological activities measuring the same functional activity of the gland. Better understanding is needed of the physiological processes involved in the production of adrenal cholesterol and its relationship to hormone production.
Summary. Two days after hypophysectomy, the pyridoxine-deficient rat treated with ACTH had the same amount of adrenal ascorbic acid depletion and adrenal weight increase as did the pair weighed and ad libitum controls but like these controls no decrease in adrenal cholesterol. When intact animals were subjected to hypoxia, however, the pyridoxinedeficient group, although able to maintain adrenal weights and adrenal ascorbic acid content as did the pair weighed and ad libitum groups, clearly failed to show the adrenal cholesterol depletion characteristic of the latter groups. The depletion of adrenal cholesterol is apparently not controlled by the same mechanism involved in adrenal hypertrophy and adrenal ascorbic acid depletion. gram body weight respectively. The rats were housed individually in an air-conditioned unit permitting constant temperature and humidity. Radioactive material was administered by the intraperitoneal route. After 8 months periodic x-rays were taken of the entire skeleton of most animals and a routine x-ray of the skeleton was made of every rat at the time of death.
Results. Table I shows the number of animals in each group originally, the number alive after 8 months and their subsequent life span, and the incidence of malignant neoplasms. In calculating incidence those rats in the Q.25, 0.5, 1.0 and 2.0 pc groups which died before 8 months and those in the 3.0 and 3.5 pc groups which died before 5 months, i.e., considerably before the latent period for tumor development, were not included. Also lymphosarcoma, which occurred in one animal in each of the 0.25, 1, 2 and 3.5 pc groups was omitted since this tumor has occasionally been observed to occur spontaneously in the C. F. Wistar strain.
Outside of one rat with lymphosarcoma, the 43 animals receiving the 0.25 or 0.5 pc dose of P32 did not develop tumors. In the groups where dosage ranged from 1.0 to 3.5 pc of Pa, neoplasms occurred in from 22 to 50% of animals. The greatest frequency was in rats which received the highest dose of radioactive phosphorus. However, among the 1, 2 and 3 pc groups there was no indication that the incidence of malignancy decreased with dosage in the manner described for radioactive strontium (2). Table I1 gives the number of rats in each group with neoplasm, the latent period for tumor development, and the types of neoplasm. Only 2 types were observed, osteo-genic sarcoma and squamous cell carcinoma. The former was more common and occurred in a total of 18 animals with the following locations: femur 7, spine 4, tibia 3, jaw 3, and humerus 1. There were metastases in 10 of the 18 rats, usually to lungs and regional lymph nodes. Six animals developed an extensive ulcerating squamous cell carcinoma involving one side of the face with no metastasis. Except for one rat injected with 1 pc of Pa per gram body weight, the squamous cell tumors occurred in animals which received the highest dose of radioactive phosphorus, i.e., 3 .5 pc per gram body weight.
Discussion. The overall incidence of neoplasms produced by smaller amounts of P32 was less than that previously obtained with very high doses of the isotope( 1 ) . In addition the latent period of tumor development appeared to be lengthened when the dose of Ps was lowered. Thus the mean time of development was 19, 14 and 10.5 months respectively for animals given 1, 2 and 3 pc of P32 per gram body weight. This observation is limited by the fact that these periods represent detection of the neoplasm rather than the exact time of origin.
The two types of malignant tumor induced in this study were the same as those which resulted from large doses of Pa. Osteogenic sarcoma was the most common neoplasm.
This would be anticipated since Pa is deposited heavily in the skeleton and causes radiation osteitis which is a precursor to malignant change. The second variety of neoplasm resulting from Pa was squamous cell carcinoma of the face. This appeared to arise below the skin rather than from the surface and to invade the subcutaneous soft tissues, bones of the face and orbit. While the exact origin has not been determined, the probable source is epithelium closely approximated to bone, i.e., lining of accessory nasal sinuses, nasopharynx, and roof of mouth, and presumably irradiated from this site.
The validity of our data obviously depends on the spontaneous incidence in rats of osteogenic sarcoma and cancer of the face. As far as is known, these tumors are rare among normal animals of the Wistar strain. In 58 such rats followed through their lifetime, we found one instance of osteogenic sarcoma and none of squamous cell carcinoma (3) . Ratcliffe(4) reported that about 5% of rats in a Wistar stock colony developed neoplasm and that among the 75 tumor-bearing animals comprising this 5% there was one osteogenic sarcoma and one carcinoma of the skin. The latter arose from the tip of the snout. A very low overall incidence of these two malignant neoplasms has also been described in other strains of the rat (43). In this study the smallest dose of P32 which induced tumors was 1 pc/gram body weight and this corresponds to 70 mc for a early mortality f rom radiation is potentially greater and the life span of the surviving animals shorter.
Summary. 1. Single doses of radioactive phosphorus, administered internally to rats in amounts of from 1 to 3.5 pc/gram body weight, proved carcinogenic. Two types of malignant neoplasms were produced, i.e., osteogenic sarcoma and carcinoma of the face.
The incidence of neoplasms ranged from 22
to 50%. The latent period of tumor development was lengthened with smaller doses of Pa. 3 Studies with Esckerickia coZi have shown the same morphological effects, i.e., the inhibithat certain organic chemicals, such as tion of multiplication without inhibition of nitrogen mustards, trie thylenemelamine, diaculture growth or mass, as alpha or X-irradiazouracil? and Other diazo compounds produce tion ( 1,2 and produce similar biochemical
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